18-254 - The RE-ENERGIZE Study: RandomizEd Trial of ENtERal Glutamine to minimIZE Thermal Injury
Status: open
Effects of Enteral Glutamine Supplementation on Mortality and Infectious Morbidity in Severely Burned Patients: a Multi-center Pilot Trial
Treatment for Thermal Burns
Contact Us
If you have questions about this trial or are interested in participating, please contact this Clinical Trial’s Coordinator by phone at 251-471-7988 or by email at kbose@health.southalabama.edu.
Description
The specific aims of the study are to determine the overall treatment effect and safety of glutamine in burn patients. Clinical outcomes will be: mortality, time to discharge alive, incidence of acquired bacteremia due to Gram negative organisms, hospital mortality, duration of mechanical ventilation, ICU stay and hospital stay. The cost-effectiveness of glutamine administration will also be measured if the results show a decrease in length of care or a reduced incidence of acquired bacteremia due to Gram negative organisms with glutamine.
Sponsors
This trial is sponsored by Stratatech.Providers Associated With This Trial
Principle Investigator
![Andrew C. Bright, D.O.]()
View ProfileAndrew C. Bright, D.O.Trauma/Emergency General/Burn SurgeonAssistant Professor of Surgery, Burn Unit Medical Director
Sub Investigators
![Lintner alicia]()
View ProfileAlicia C. Lintner, CRNPNurse Practitioner
